Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1)
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £1,677,290 |
|---|---|
| Status | complete |
| Category (CPV) | 33696200 |
| Deadline | 31 Mar 2025 |
| Contract start | 1 Apr 2025 |
| Contract end | 31 Mar 2027 |
| Procedure | selective |
| SME suitable | No |
| OCID | ocds-b5fd17-05c35d6c-e5e5-4618-9fc5-a047424e85cf |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Revvity (UK) Limited | £1,677,290 | 30 Mar 2025 | active |
description
Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories in England
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 27 Aug 2025 | Award (award) | · | b799e693-eab3-4435-a855-4f8f34619110-860909 |
more from NHS England
- Market Engagement Event for East ofEngland prisons · £0 · 11 Sept 2026
- Finance Transformation & Enablement Project Support · £7,944,879 · 10 Sept 2026
- Provision of Public Consultation and Engagement Services for the UISPC · £155,000 · 8 Sept 2026
- Targeted Lung Health Checks National Licences · £1,900,000 · 8 Sept 2026
- Adult Screening and Personalisation Digital Delivery Services · £215,163,316 · 4 Sept 2026
- Step into the NHS - Schools Programme · £65,800 · 2 Sept 2026
- Website hosting and support for hee.nhs.uk and healthcareers.nhs.uk · £168,336 · 1 Sept 2026
- NHS Login Run and Maintain 2 · £30,000,000 · 28 Aug 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- PSD11526 Red Cell Genotyping · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £680,051
- Oncotype DX Breast recurrence score test · Leeds Teaching Hospital NHS Trust · £191,700
- YAS 163 2025_26 (DA FW) Point of Care Test Equipment and Associated Products · Yorkshire Ambulance Service NHS Trust · £140,310
- Supply of 3rd Party Quality Controls · NHS Blood and Transplant · £162,530
- Contract Award Notice for the Provision of Alloseq Tx17 NGS HLA Testing Kits · Manchester University NHS Foundation Trust
- HLA TISSUE TYPING FOR BONE MARROW VOLUNTEER DONORS PERFORMED BY 3RD PARTY SUPPLIER · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £140,000
- C245831 - Provision of Dried Blood Spot collection and preservation cards · UK Health Security Agency · £34,800
- PPE1000892 Direct Award for Molecular Biology Reagents · University of Glasgow · £247,500
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.